The classical paradigm for clinical mismatch repair deficiency asserts that dMMR is attributable to the loss of MLH1/PMS2 in most cases, to the loss of MSH2/MSH6 in a minority of cases, and to the isolated loss of individual MMR proteins in very rare cases. Here, MSH2 is linked to mismatch repair cancer syndrome 1.